National Institute of Allergy and Infectious Diseases- Research Projects

Active

Assistance listing
93.8RP
Agency
Grant awards
16 $33,097,577 in federal obligations

Program facts

Assistance type
  • Grant
Treasury account
  • 75-0885-0-1-552

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The National Institute of Allergy and Infectious Diseases (NIAID) funds basic and applied research into infectious, immunologic, and allergic diseases under Assistance Listing 93.8RP, with peer review and advisory council evaluation determining award decisions based on scientific merit, program relevance, and fiscal availability.

The program supports research projects at universities and research organizations investigating disease understanding, treatment, and prevention across the full spectrum of NIAID's scientific scope. Funded activities span basic mechanistic research, translational studies, and applied work aimed at improving public health outcomes and protecting communities from disease threats. The program operates on a competitive cycle in which renewal applications compete alongside new proposals; renewals require an active or recently active NIH research project grant and the same Principal Investigator unless justified otherwise.

Grant applications flow through grants.gov and are assigned by the Center for Scientific Review to a Scientific Review Group, which assigns an overall impact score or percentile. A second-level peer review by NIAID's advisory council confirms concurrence with initial peer review findings, assesses program relevance, and evaluates fiscal considerations. NIAID program staff then assess applications against scientific and technical merit, programmatic priorities and set-asides, and budget availability in the funding fiscal year. The NIAID Grants Management Officer issues the Notice of Award, the sole document obligating federal funds, specifying the approved budget period within the project period.

The source does not provide recent grant award portfolio data, recent award examples, or information on current grant opportunities. It does not disclose typical award magnitudes, funding concentration among NIAID divisions or centers, assistance-type mix, or the award cadence. The source establishes the program structure and evaluation criteria but does not support assessment of current funding volume or competitive positioning.

Objective and description

Objective

Provide funding to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.

Description

Provide funding to universities and research organizations to study infectious, immunologic, and allergic diseases. These grants and cooperative agreements serve researchers and institutions working to improve public health and protect communities from disease threats. Focus on supporting innovative research that addresses urgent and emerging health challenges, helping to advance scientific knowledge and improve health outcomes for people everywhere.

How to apply

Criteria for selecting proposals

he following will be considered in making funding decisions: scientific and technical merit of the proposed project as determined by scientific peer review, availability of funds, relevance of the proposed project to program priorities. Assessing the importance/impact of the proposed study and its goals. Evaluating the quality of the experimental design and approach. The ability of the proposed investigator or research group to successfully execute the project. Examine whether the proposed resources, infrastructure, and institutional facilities are sufficient to support the project. Budgetary considerations are reviewed to determine the necessity of the components requested. This entails examining whether the proposed expenditures align well with the activities and scale of the project. Determining whether all items requested are essential for successful execution.

Award procedure

Applicants submit the grant application in grants.gov following guidance provided in the Notice of Funding Opportunity (NOFO). Center for Scientific Review (CSR) then assigns the application. A peer review process by Scientific Review Group (SRG) determines an overall impact score or percentile. A second level peer review is done by NIAID's advisory council which determines if there is concurrence with the initial peer review, program relevance, and fiscal considerations. NIAID selects proposals based on several factors including scientific and technical merit, programmatic priorities/set-asides, and budget availability that fiscal year. The Council makes recommendations to NIAID leadership. After advisory council review NIAID program staff evaluates applications. NIAID officials under delegated HHS authority consider all factors and make funding decisions. The NIAID Grants Management Officer (GMO) issues a Notice of Award (NOA) and only the GMO has authority to obligate federal funds. The NOA is the legally binding document which obligates federal funds. The NOA specifies the approved budget period which is the specific time interval within the project period for which funds are provided.

Renewals

Renewals compete with new applications in peer review. You must have an active or recently active NIH research project grant. The same Principal Investigator must remain in place unless there is a justifiable reason for a new PI. Renewal applications use the SF 424 format.

Grant opportunities

Grant awards

Award Recipient Federal obligations Awarded
Requirements to traverse the bony channels linking the skull bone marrow and dura mater - IT had long been thought that… RAI198907UHUHN8 New York University $655,663
Coordination of innate and cellular mucosal immunity in sars-COV-2 clearance R01AI188896 Emory University $2,070,048
Immune analysis of the hbsag seroclearance response terminating chronic HBV R01AI187598 The Regents Of The University Of California. San Francisco $2,356,184
Plasmodium and anopheles midgut interactive proteins influence malaria transmission R01AI179943 Florida International University $1,992,161
Haemophilus influenzae lipoprotein fusion vaccine and lipoprotein vaccine platform development R01AI187168 The Rochester General Hospital $1,169,311
PELLINO1 as a regulator of antiviral immunity in the epidermis R01AI182537 Temple University-Of The Commonwealth System Of Higher Education $1,137,238
Manipulation of the DNA damage response and the proteome on viral genomes during herpes simplex virus (HSV) infection R01AI187335 The Children's Hospital Of Philadelphia $1,928,619
Advancing crispr-based genome editing strategies for managing aedes aegypti mosquito populations R01AI187493 University Of Texas Health Science Center At Houston $1,310,511
Defining the molecular interface of wolbachia ankyrin-host interaction R01AI178815 Trustees Of Indiana University $1,283,455
ION channels regulating plasma cell differentiation and humoral immunity R01AI175276 New York University $2,587,501

Latest 10 of 16 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 15 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2027 To date $9,154,557

Quick answers

What is Assistance Listing 93.8RP?

Assistance Listing 93.8RP is National Institute of Allergy and Infectious Diseases- Research Projects, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for National Institute of Allergy and Infectious Diseases- Research Projects?

Its CFDA number is 93.8RP: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.8RP awarded?

16 grant awards under 93.8RP have obligated $33,097,577 in federal funds to 15 recipients.

Who receives the most funding from 93.8RP?

The recipients obligated the most under National Institute of Allergy and Infectious Diseases- Research Projects are The General Hospital Corporation ($3,248,486), New York University ($3,243,164) and Yale Univ ($3,211,380).

Are there open grant opportunities under 93.8RP?

5 listed opportunities under 93.8RP are open or forecasted. The latest, Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed), was posted on June 24, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program